Dynavax Technologies Corp (DVAX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Ryan Spencer
Employees:
350
2929 SEVENTH STREET, SUITE 100, BERKELEY, CA 94710
5108485100

The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in the vaccine. The company was formerly known as Double Helix Corporation.

Data derived from most recent annual or quarterly report
Market Cap 1.466 Billion Shares Outstanding127.687 Million Avg 30-day Volume 1.22 Million
P/E Ratio5.3246 Dividend Yield0.0 EPS1.87
Price to Revenue1.9141 Debt to Equity0.3935 EBITDA221.637 Million
Price to Book Value2.2261 Operating Margin33.9392 Enterprise Value824.804 Million
Current Ratio9.071 EPS Growth1 Quick Ratio8.27
1 Yr BETA 1.288 52-week High/Low 17.48 / 9.42 Profit Margin35.9913
Operating Cash Flow Growth-43.0159 Altman Z-Score2.8315 Free Cash Flow to Firm 92.257 Million
Earnings Report2023-08-03
View SEC Filings from DVAX instead.

View recent insider trading info

Funds Holding DVAX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DVAX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-05-26:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
  • 8-K: filed on 2022-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    1 Million total shares from 2 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KISNER DANIEL L

    • Director
    12,214 2023-05-26 1

    CANO FRANCIS

    • Director
    31,548 2023-05-26 2

    MYERS SCOTT DUNSETH

    • Director
    20,089 2023-05-26 1

    PHILLIPS PEGGY V

    • Director
    38,447 2023-05-26 1

    EASTLAND JULIA MARIE

    • Director
    10,714 2023-05-26 1

    HACK ANDREW A. F.

    • Director
    2,925,714 2023-05-26 4

    SUN ELAINE D

    • Director
    18,750 2023-05-26 1

    MACGREGOR BRENT

    • Director
    10,714 2023-05-26 1

    PARADISO PETER R.

    • Director
    13,714 2023-05-26 1

    NOVACK DAVID F PRESIDENT & COO

    • Officer
    3,187 2023-05-04 7

    JANSSEN ROBERT SVP AND CMO

    • Officer
    49,925 2023-02-27 5

    SPENCER RYAN CEO AND DIRECTOR

    • Officer
    • Director
    178,459 2023-02-27 4

    MACDONALD KELLY SVP AND CFO

    • Officer
    2,359 2023-02-27 2

    BURGESS JUSTIN CHIEF ACCOUNTING OFFICER

    • Officer
    0 2023-02-27 3

    RICCIARDI NATALE S

    • Director
    27,857 2022-05-26 0

    OSTRACH MICHAEL S SENIOR VICE PRESIDENT

    • Officer
    0 2021-02-03 0

    ORONSKY ARNOLD L

    • Director
    0 2020-05-28 0

    JOHNSON DAVID LOUIS VICE PRESIDENT

    • Officer
    48,380 2020-03-13 0

    COFFMAN ROBERT SENIOR VICE PRESIDENT

    • Officer
    77,768 2019-06-02 0

    GRAY EDDIE CEO AND DIRECTOR

    • Officer
    • Director
    304,597 2019-06-02 0

    CARSON DENNIS

    • Director
    0 2019-05-30 0

    BREGE LAURA

    • Director
    0 2019-05-30 0

    PLOTKIN STANLEY A

    • Director
    0 2017-06-02 0

    GILBERT DENISE

    • Director
    0 2014-05-28 0

    DINA DINO

    • Director
    0 2014-05-28 0

    TUCK STEPHEN F VP, GLOBAL TECHNICAL OPS

    • Officer
    0 2013-02-05 0

    LEW JENNIFER VP, FINANCE & PAO

    • Officer
    0 2013-02-05 0

    MARTIN J TYLER PRESIDENT, CMO & DIRECTOR

    • Officer
    • Director
    222,089 2012-11-16 0

    KESSEL MARK

    • Director
    3,031,431 2012-10-16 0

    LARSON CHRISTINE R VP AND CHIEF FINANCIAL OFFICER

    • Officer
    0 2012-08-13 0

    JANOWICZ ZBIGNIEW CEO DYNAVAX EUROPE

    • Officer
    0 2012-03-09 0

    LAWRENCE DAVID M

    • Director
    0 2010-05-12 0

    BUC NANCY L

    • Director
    0 2010-05-12 0

    SYMPHONY CAPITAL PARTNERS LP

    SYMPHONY CAPITAL GP, L.P.

    SYMPHONY GP, LLC

    SYMPHONY STRATEGIC PARTNERS LLC

    TARANTO HARRI V

    • Director
    • 10% Owner
    • SEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKS
    9,031,431 2010-04-16 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND II LP

    BVF INVESTMENTS LLC

    LAMPERT MARK N

    BVF INC/IL

    • 10% Owner
    • DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER
    17,115,404 2009-09-10 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND II LP

    BVF INVESTMENTS LLC

    BVF INC/IL

    • 10% Owner
    • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
    25,254,628 2009-06-03 0

    SMELTZER DEBORAH A VP, OPERATIONS & CFO

    • Officer
    0 2009-03-10 0

    FLYNN JAMES E

    DEERFIELD CAPITAL LP

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO /NY

    DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

    DEERFIELD PRIVATE DESIGAN FUND L P

    DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

    • 10% Owner
    No longer subject to file 2008-10-22 0

    SANDERS MARTIN E EVP AND CDO

    • Officer
    0 2008-10-03 0

    FLYNN JAMES E

    DEERFIELD CAPITAL LP

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO /NY

    DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

    DEERFIELD PRIVATE DESIGAN FUND L P

    • 10% Owner
    1,250,000 2007-07-18 0

    DEERFIELD PRIVATE DESIGAN FUND L P

    • 10% Owner
    0 2007-07-18 0

    DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

    • 10% Owner
    0 2007-07-18 0

    HENN TIMOTHY G VP, FINANCE & ADMINISTRATION

    • Officer
    20,000 2007-02-02 0

    VAN NEST GARY A VP, PRECLINICAL RESEARCH

    • Officer
    25,000 2007-02-02 0

    JANNEY DANIEL

    • NO LONGER A DIRECTOR
    10,030 2006-11-14 0

    FLYNN JAMES E

    DEERFIELD CAPITAL LP

    DEERFIELD PARTNERS, LP

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO /NY

    DEERFIELD INTERNATIONAL LTD

    DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

    • 10% Owner
    • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
    4,851,538 2006-10-04 0

    LESCHLY JAN

    • Director
    10,000 2006-06-14 0

    FLYNN JAMES E

    DEERFIELD CAPITAL LP

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MANAGEMENT CO /NY

    DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

    • 10% Owner
    • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
    328,447 2006-05-15 0

    LEVITT DANIEL J VICE PRESIDENT

    • Officer
    50,000 2006-02-14 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    PARADISO PETER R. - Director

    2023-05-31 17:30:22 -0400 2023-05-26 A 5,357 a 13,714 direct

    HACK ANDREW A. F. - Director

    2023-05-31 17:43:23 -0400 2023-05-26 A 22,500 a 22,500 direct

    HACK ANDREW A. F. - Director

    2023-05-31 17:43:23 -0400 2023-05-26 A 5,357 a 10,714 direct

    MYERS SCOTT DUNSETH - Director

    2023-05-31 17:35:33 -0400 2023-05-26 A 22,500 a 22,500 direct

    MYERS SCOTT DUNSETH - Director

    2023-05-31 17:35:33 -0400 2023-05-26 A 5,357 a 20,089 direct

    SUN ELAINE D - Director

    2023-05-31 17:34:51 -0400 2023-05-26 A 22,500 a 22,500 direct

    SUN ELAINE D - Director

    2023-05-31 17:34:51 -0400 2023-05-26 A 5,357 a 18,750 direct

    PHILLIPS PEGGY V - Director

    2023-05-31 17:34:02 -0400 2023-05-26 A 22,500 a 22,500 direct

    PHILLIPS PEGGY V - Director

    2023-05-31 17:34:02 -0400 2023-05-26 A 5,357 a 38,447 direct

    PARADISO PETER R. - Director

    2023-05-31 17:30:22 -0400 2023-05-26 A 22,500 a 22,500 direct

    MACGREGOR BRENT - Director

    2023-05-31 17:26:42 -0400 2023-05-26 A 22,500 a 22,500 direct

    MACGREGOR BRENT - Director

    2023-05-31 17:26:42 -0400 2023-05-26 A 5,357 a 10,714 direct

    EASTLAND JULIA MARIE - Director

    2023-05-31 17:23:48 -0400 2023-05-26 A 22,500 a 22,500 direct

    EASTLAND JULIA MARIE - Director

    2023-05-31 17:23:48 -0400 2023-05-26 A 5,357 a 10,714 direct

    KISNER DANIEL L - Director

    2023-05-31 17:25:19 -0400 2023-05-26 A 22,500 a 22,500 direct

    KISNER DANIEL L - Director

    2023-05-31 17:25:19 -0400 2023-05-26 A 5,357 a 12,214 direct

    CANO FRANCIS - Director

    2023-05-31 17:20:32 -0400 2023-05-26 A 22,500 a 22,500 direct

    CANO FRANCIS - Director

    2023-05-31 17:20:32 -0400 2023-05-26 A 5,357 a 31,548 direct

    HACK ANDREW A. F. - Director see footnotes

    2023-05-19 16:30:37 -0400 2023-05-18 S 1,000,000 $10.55 d 2,915,000 indirect 0.8189 2.1838 2.2748 3 0.0 1

    NOVACK DAVID F - Officer PRESIDENT & COO

    2023-05-05 20:58:23 -0400 2023-05-04 S 17,515 $10.90 d 3,187 direct -1.0999 5.0412 5.0412 6 -1.0999 2

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 22:15:04 UTC 4.7657 0.3043 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 21:45:04 UTC 4.7657 0.3043 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 21:15:05 UTC 4.7657 0.3043 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 20:45:03 UTC 4.7657 0.3043 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 20:15:04 UTC 4.7785 0.2915 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 19:45:03 UTC 4.7785 0.2915 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 19:15:04 UTC 4.7785 0.2915 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 18:45:03 UTC 4.7823 0.2877 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 18:15:04 UTC 4.7823 0.2877 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 17:45:04 UTC 4.7823 0.2877 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 17:15:04 UTC 4.7823 0.2877 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 16:45:04 UTC 4.7705 0.2895 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 16:15:04 UTC 4.7705 0.2895 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 15:45:03 UTC 4.7705 0.2895 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 15:15:04 UTC 4.7705 0.2895 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 14:45:04 UTC 4.7705 0.2895 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 14:15:04 UTC 4.7705 0.2895 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 13:45:04 UTC 4.7997 0.2603 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 13:15:04 UTC 4.7997 0.2603 1800000
    DYNAVAX TECHNOLOGIES CORP DVAX 2023-06-01 12:45:04 UTC 4.7997 0.2603 1800000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Franklin Alternative Strategies Funds- K2 Alternative Strategies Fund DVAX -80095.0 shares, $-824978.5 2023-02-28 N-PORT
    JNL Series Trust- JNL Multi-Manager Alternative Fund DVAX -190984.0 shares, $-1873553.04 2023-03-31 N-PORT
    LAZARD FUNDS INC- Lazard Enhanced Opportunities Portfolio DVAX -639.0 shares, $-6268.59 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments